VIN-CENT WUChen, Jui-YiJui-YiChenYEN-HUNG LINWang, Cheng-YiCheng-YiWangLai, Chih-ChengChih-ChengLai2023-12-082023-12-082023-09-2716841182https://scholars.lib.ntu.edu.tw/handle/123456789/637619Primary Aldosteronism (PA) is a common subtype of hypertension that increases the risk of adverse cardiovascular and kidney events. The impact of COVID-19 on patients with PA is not well understood. This study aimed to investigate the impact of COVID-19 on patients with PA and compare their outcomes with hypertensive patients with essential hypertension.enCOVID-19; Critical care; MACE; MAKE; Mortality; Primary aldosteronism; TAIPAI[SDGs]SDG3journal article10.1016/j.jmii.2023.09.005378279532-s2.0-85173245961